Edwards Lifesciences Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$1,648,600	$1,569,600	$1,553,100	$1,532,200
Gross Profit	1,289,300	1,229,000	1,209,600	1,189,600
EBITDA	514,700	133,100	387,600	400,200
EBIT		90,400	348,400	362,100
Net Income	380,700	91,200	291,100	329,800
Net Change In Cash	1,648,600	1,569,600	1,553,100	1,532,200
Free Cash Flow	-21,100	353,500	516,200	240,900
Cash	2,446,500	2,938,500	2,685,600	3,272,800
Basic Shares	580,700	581,800	585,700	587,900

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$6,067,600	$5,439,500	$6,004,800	$5,382,400
Gross Profit	4,740,700	4,322,000	4,625,000	4,215,200
EBITDA	1,429,500	1,723,100	1,534,100	1,960,400
EBIT	1,272,900	1,567,900	1,534,100	1,793,600
Net Income	1,073,500	4,174,600	1,402,400	1,521,900
Net Change In Cash	6,067,600	5,439,500	6,004,800	5,382,400
Cost of Revenue				-114,000
Free Cash Flow	1,335,000	289,900	629,500	953,400
Cash	2,938,500	3,045,200	1,132,300	769,000
Basic Shares	585,800	599,300	609,400	624,200